Literature DB >> 30277478

PD-L1 in tumor microenvironment mediates resistance to oncolytic immunotherapy.

Dmitriy Zamarin, Jacob M Ricca, Svetlana Sadekova, Anton Oseledchyk, Ying Yu, Wendy M Blumenschein, Jerelyn Wong, Mathieu Gigoux, Taha Merghoub, Jedd D Wolchok.   

Abstract

Entities:  

Year:  2018        PMID： 30277478      PMCID： PMC6205393          DOI： 10.1172/JCI125039

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  16 in total

1.  Recombinant Adenovirus Expressing a Soluble Fusion Protein PD-1/CD137L Subverts the Suppression of CD8+ T Cells in HCC.

Authors:  Yonghui Zhang; Hailin Zhang; Mei Wei; Tao Mou; Tao Shi; Yanyu Ma; Xinyu Cai; Yunzheng Li; Jie Dong; Jiwu Wei
Journal:  Mol Ther       Date:  2019-08-05       Impact factor: 11.454

2.  Intravesical VAX014 Synergizes with PD-L1 Blockade to Enhance Local and Systemic Control of Bladder Cancer.

Authors:  Shingo Tsuji; Katherine Reil; Kinsey Nelson; Veronica H Proclivo; Kathleen L McGuire; Matthew J Giacalone
Journal:  Cancer Immunol Res       Date:  2022-08-03       Impact factor: 12.020

3.  Avian Paramyxovirus 4 Antitumor Activity Leads to Complete Remissions and Long-term Protective Memory in Preclinical Melanoma and Colon Carcinoma Models.

Authors:  Aryana Javaheri; Yonina Bykov; Ignacio Mena; Adolfo García-Sastre; Sara Cuadrado-Castano
Journal:  Cancer Res Commun       Date:  2022-07-07

4.  The Novel Tumor Microenvironment-Related Prognostic Gene AIF1 May Influence Immune Infiltrates and is Correlated with TIGIT in Esophageal Cancer.

Authors:  Xiaoling Xu; Ding Wang; Na Li; Jiamin Sheng; Mingying Xie; Zichao Zhou; Guoping Cheng; Yun Fan
Journal:  Ann Surg Oncol       Date:  2021-11-09       Impact factor: 4.339

5.  STAT3 Contributes To Oncolytic Newcastle Disease Virus-Induced Immunogenic Cell Death in Melanoma Cells.

Authors:  Xiaoyan Shao; Xueke Wang; Xianling Guo; Ke Jiang; Tian Ye; Jianhua Chen; Juemin Fang; Linaer Gu; Sitong Wang; Guirong Zhang; Songshu Meng; Qing Xu
Journal:  Front Oncol       Date:  2019-05-29       Impact factor: 6.244

6.  Chimeric tumor modeling reveals role of partial PDL1 expression in resistance to virally induced immunotherapy.

Authors:  Mee Y Bartee; Parker C Dryja; Eric Bartee
Journal:  J Immunother Cancer       Date:  2019-01-16       Impact factor: 13.751

7.  Tumor suppression of novel anti-PD-1 antibodies mediated through CD28 costimulatory pathway.

Authors:  Juan-Luis Loredo-Varela; Victor Joo; Craig Fenwick; Céline Pellaton; Alex Farina; Navina Rajah; Line Esteves-Leuenberger; Thibaut Decaillon; Madeleine Suffiotti; Alessandra Noto; Khalid Ohmiti; Raphael Gottardo; Winfried Weissenhorn; Giuseppe Pantaleo
Journal:  J Exp Med       Date:  2019-05-23       Impact factor: 14.307

8.  Oncolytic Maraba virus armed with tumor antigen boosts vaccine priming and reveals diverse therapeutic response patterns when combined with checkpoint blockade in ovarian cancer.

Authors:  A J Robert McGray; Ruea-Yea Huang; Sebastiano Battaglia; Cheryl Eppolito; Anthony Miliotto; Kyle B Stephenson; Amit A Lugade; Gill Webster; Brian D Lichty; Mukund Seshadri; Danuta Kozbor; Kunle Odunsi
Journal:  J Immunother Cancer       Date:  2019-07-17       Impact factor: 12.469

9.  TGF-β suppresses type 2 immunity to cancer.

Authors:  Ming Liu; Fengshen Kuo; Kristelle J Capistrano; Davina Kang; Briana G Nixon; Wei Shi; Chun Chou; Mytrang H Do; Efstathios G Stamatiades; Shengyu Gao; Shun Li; Yingbei Chen; James J Hsieh; A Ari Hakimi; Ichiro Taniuchi; Timothy A Chan; Ming O Li
Journal:  Nature       Date:  2020-10-21       Impact factor: 69.504

10.  STING agonist loaded lipid nanoparticles overcome anti-PD-1 resistance in melanoma lung metastasis via NK cell activation.

Authors:  Takashi Nakamura; Takanori Sato; Rikito Endo; Shun Sasaki; Naomichi Takahashi; Yusuke Sato; Mamoru Hyodo; Yoshihiro Hayakawa; Hideyoshi Harashima
Journal:  J Immunother Cancer       Date:  2021-07       Impact factor: 13.751
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.